StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PTIX

Protagenic Therapeutics, Inc.

PTIX OTC Pharmaceutical Preparations EDGAR ↗
$0.18
+0.02 +9.58%

Key statistics

from XBRL data in SEC filings
Market cap
$331K
Revenue (TTM)
$0.00
Net income (TTM)
-$5.16M
EPS (TTM)
$-3.45
P/E ratio
Dividend yield
Free cash flow
-$4.37M
Cash
$2.21M
Total assets
$4.43M
Gross margin
52-week range
$0.13 – $6.20

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Apr 7, 2026 10-Q Quarter ended 2025-12-31 Mar 9, 2026 8-K Director or officer change Mar 3, 2026 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Other events Feb 24, 2026 8-K Delisting notice or listing-rule failure Jan 5, 2026 10-Q Quarter ended 2025-09-30 Nov 26, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Nov 26, 2025 8-K Director or officer change Nov 5, 2025 8-K Other events Oct 31, 2025 8-K/A Sep 17, 2025 8-K/A Aug 28, 2025 8-K Delisting notice or listing-rule failure; Changed accountants; Regulation FD disclosure Aug 22, 2025 8-K Exit or disposal costs; Director or officer change; Amended charter or bylaws; Other events Aug 13, 2025 8-K Regulation FD disclosure Jul 30, 2025 8-K Director or officer change Jul 24, 2025 8-K Modified rights of security holders Jun 27, 2025 8-K Regulation FD disclosure May 21, 2025 8-K Entered a material agreement; Unregistered sale of equity May 20, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure; Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Amended charter or bylaws May 5, 2025 8-K Regulation FD disclosure Apr 29, 2025 8-K Shareholder vote results Apr 18, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Feb 24, 2025 8-K Shareholder vote results Feb 24, 2025 8-K Delisting notice or listing-rule failure Jan 29, 2025 8-K Delisting notice or listing-rule failure Jan 16, 2025 8-K Entered a material agreement Jan 10, 2025 8-K Other events Dec 3, 2024 8-K Delisting notice or listing-rule failure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Regulation FD disclosure; Other events Nov 5, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 30, 2024 8-K Other events Sep 18, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Delisting notice or listing-rule failure Jul 26, 2024 8-K Delisting notice or listing-rule failure May 24, 2024 8-K Regulation FD disclosure May 22, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024